Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Everolimus (RAD001): first systemic treatment for subependymal giant cell astrocytoma associated with tuberous sclerosis complex.
Józwiak S, Stein K, Kotulska K.
Future Oncol. 2012 Dec;8(12):1515-23. doi: 10.2217/fon.12.146. Review.
Related citations
Cardiac rhabdomyomas in tuberous sclerosis patients: a case report and review of the literature.
Benyounes N, Fohlen M, Devys JM, Delalande O, Moures JM, Cohen A.
Arch Cardiovasc Dis. 2012 Aug-Sep;105(8-9):442-5. doi: 10.1016/j.acvd.2012.01.009. Epub 2012 Apr 13. Review.
Synaptic plasticity and learning in animal models of tuberous sclerosis complex.
Kirschstein T.
Neural Plast. 2012;2012:279834. doi: 10.1155/2012/279834. Epub 2012 Jul 15. Review.
Primary care management of tuberous sclerosis complex in children.
Manohara D.
J Am Acad Nurse Pract. 2012 Jul;24(7):391-9. doi: 10.1111/j.1745-7599.2012.00734.x. Epub 2012 May 3. Review.
Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations.
Curatolo P, Jóźwiak S, Nabbout R; TSC Consensus Meeting for SEGA and Epilepsy Management.
Eur J Paediatr Neurol. 2012 Nov;16(6):582-6. doi: 10.1016/j.ejpn.2012.05.004. Epub 2012 Jun 12. Review.
Targeted treatment trials for tuberous sclerosis and autism: no longer a dream.
Sahin M.
Curr Opin Neurobiol. 2012 Oct;22(5):895-901. doi: 10.1016/j.conb.2012.04.008. Epub 2012 May 4. Review.
Molecular therapies for tuberous sclerosis and neurofibromatosis.
Franz DN, Weiss BD.
Curr Neurol Neurosci Rep. 2012 Jun;12(3):294-301. doi: 10.1007/s11910-012-0269-4. Review.
Emerging treatments in the management of tuberous sclerosis complex.
Kohrman MH.
Pediatr Neurol. 2012 May;46(5):267-75. doi: 10.1016/j.pediatrneurol.2012.02.015. Review.
Tuberous sclerosis and epilepsy: role of astrocytes.
Wong M, Crino PB.
Glia. 2012 Aug;60(8):1244-50. doi: 10.1002/glia.22326. Epub 2012 Mar 21. Review.
Hemorrhagic subependymal giant cell astrocytoma in a patient with tuberous sclerosis: case report and review of the literature.
Wadhwa R, Khan IS, Thomas JO, Nanda A, Guthikonda B.
Neurol India. 2011 Nov-Dec;59(6):933-5. doi: 10.4103/0028-3886.91394. Review. No abstract available.
Well-differentiated pancreatic neuroendocrine carcinoma in tuberous sclerosis--case report and review of the literature.
Arva NC, Pappas JG, Bhatla T, Raetz EA, Macari M, Ginsburg HB, Hajdu CH.
Am J Surg Pathol. 2012 Jan;36(1):149-53. doi: 10.1097/PAS.0b013e31823d0560. Review.
Neuroendocrine tumor of the pancreas in a patient with tuberous sclerosis: a case report and review of the literature.
Díaz Díaz D, Ibarrola C, Goméz Sanz R, Pérez Hurtado B, Salazar Tabares J, Colina Ruizdelgado F.
Int J Surg Pathol. 2012 Aug;20(4):390-5. doi: 10.1177/1066896911428735. Epub 2011 Dec 14. Review.
Everolimus: in patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex.
Curran MP.
Paediatr Drugs. 2012 Feb 1;14(1):51-60. doi: 10.2165/11207730-000000000-00000. Review.
Tuberous sclerosis complex-associated angiomyolipomas: focus on mTOR inhibition.
Budde K, Gaedeke J.
Am J Kidney Dis. 2012 Feb;59(2):276-83. doi: 10.1053/j.ajkd.2011.10.013. Epub 2011 Nov 29. Review.
Appetite for destruction: the inhibition of glycolysis as a therapy for tuberous sclerosis complex-related tumors.
Csibi A, Blenis J.
BMC Biol. 2011 Oct 21;9:69. doi: 10.1186/1741-7007-9-69. Review.
Translational research: Rett syndrome and tuberous sclerosis complex.
Khwaja OS, Sahin M.
Curr Opin Pediatr. 2011 Dec;23(6):633-9. doi: 10.1097/MOP.0b013e32834c9251. Review.
Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosis.
Franz DN.
Expert Rev Anticancer Ther. 2011 Aug;11(8):1181-92. doi: 10.1586/era.11.93. Review.
mTOR inhibitors in the treatment of subependymal giant-cell astrocytomas associated with tuberous sclerosis.
Komotar RJ, Starke RM, Connolly ES, Sisti MB.
Neurosurgery. 2011 Apr;68(4):N24-5. doi: 10.1227/01.neu.0000395796.64099.76. Review. No abstract available.
Burden of disease and unmet needs in tuberous sclerosis complex with neurological manifestations: systematic review.
Hallett L, Foster T, Liu Z, Blieden M, Valentim J.
Curr Med Res Opin. 2011 Aug;27(8):1571-83. doi: 10.1185/03007995.2011.586687. Epub 2011 Jun 21. Review.
Neurosurgical treatment of tuberous sclerosis complex lesions.
Pascual-Castroviejo I.
Childs Nerv Syst. 2011 Aug;27(8):1211-9. doi: 10.1007/s00381-011-1488-8. Epub 2011 May 24. Review.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on